The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into

Mengqi Li1, Qingzheng Jiao2, Wenqiang Xin3,4

  • 1Department of Cardiovascular Surgery, Tianjin Medical University General Hospital, Tianjin, China.

Insights

Rho guanine nucleotide exchange factors (Rho GEFs) are crucial in atherosclerosis development. This review explores Rho GEF roles in atheroma, offering insights for future cardiovascular disease research.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cell Biology
  • Biochemistry

Background:

  • Atherosclerosis is a major cause of global mortality, contributing to one-third of all deaths worldwide.
  • The precise mechanisms underlying atherosclerosis remain incompletely understood.
  • The Rho GTPase family, particularly Rho A, is recognized for its significant role in arteriosclerosis development and progression.

Purpose of the Study:

  • To review current research on the relationship and interaction between Rho guanine nucleotide exchange factors (Rho GEFs) and atheroma.
  • To highlight the involvement of Rho GEFs, which function upstream of Rho GTPases, in the pathological processes of atherosclerosis.
  • To provide a reference for future investigations into atherosclerosis mechanisms.

Main Methods:

  • Literature review of existing studies on Rho GEFs and atherosclerosis.
  • Analysis of experimental findings from *in vivo* and *in vitro* research.
  • Synthesis of current knowledge regarding Rho GEF regulation in atheromatous disease.

Main Results:

  • Rho GEFs are implicated in the pathological processes of atherosclerosis.
  • Preliminary experimental data suggest Rho GEF regulation of atherosclerosis.
  • Research specifically on Rho GEFs in atherosclerosis is limited compared to their general functions.

Conclusions:

  • Rho GEFs play a role in the development and progression of atherosclerosis.
  • Further research is needed to fully elucidate the function of Rho GEFs in atheroma.
  • Understanding Rho GEF involvement may offer new therapeutic targets for cardiovascular disease.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
279
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
76